fingolimod hydrochloride has been researched along with Bronchiolitis Obliterans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirt, SW; Lehle, K; Puehler, T; Schmid, C; von Suesskind-Schwendi, M | 1 |
| Inobe, M; Konishi, K; Murakami, M; Todo, S; Uede, T; Yamada, A | 1 |
2 other study(ies) available for fingolimod hydrochloride and Bronchiolitis Obliterans
| Article | Year |
|---|---|
Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
Topics: Acute Disease; Animals; Bronchiolitis Obliterans; Chronic Disease; Drug Administration Schedule; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Lymphocytes; Male; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred WKY; Sclerosis; Sphingosine; Time Factors; Vascular Diseases | 2013 |
Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; Bronchiolitis Obliterans; CTLA-4 Antigen; Disease Models, Animal; Fingolimod Hydrochloride; Immunoconjugates; Immunoglobulin G; Immunosuppressive Agents; Lung Transplantation; Mice; Postoperative Complications; Propylene Glycols; Respiratory Mucosa; Sphingosine; Trachea | 2002 |